About 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-prop-2-enoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide
4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-prop-2-enoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide (PubChem CID 11432704) has the molecular formula C30H38N8O2
and a molecular weight of 542.69 g/mol. Its IUPAC name is 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-prop-2-enoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide.
Molecular Properties
| Compound Name | 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-prop-2-enoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide |
| PubChem CID | 11432704 |
| Molecular Formula | C30H38N8O2 |
| Molecular Weight | 542.69 g/mol |
| Exact Mass | 542.31 |
| IUPAC Name | 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-prop-2-enoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide |
| SMILES | C=CCOc1ccc2c(c1)nc(N(Cc1ccc(C(=O)Nc3nn[nH]n3)cc1)C1CCC(C(C)(C)C)CC1)n2C |
| InChI | InChI=1S/C30H38N8O2/c1-6-17-40-24-15-16-26-25(18-24)31-29(37(26)5)38(23-13-11-22(12-14-23)30(2,3)4)19-20-7-9-21(10-8-20)27(39)32-28-33-35-36-34-28/h6-10,15-16,18,22-23H,1,11-14,17,19H2,2-5H3,(H2,32,33,34,35,36,39) |
| InChIKey | RGBCQKRUFCGDTG-UHFFFAOYSA-N |
| XLogP | 5.51 |
| TPSA | 113.85 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 542.69 |
| LogP ≤ 5 | 5.51 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Analyze 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-prop-2-enoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-prop-2-enoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide?
The IUPAC name of 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-prop-2-enoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide (CID 11432704) is 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-prop-2-enoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide.
What is the SMILES notation for 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-prop-2-enoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide?
The canonical SMILES for 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-prop-2-enoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide is C=CCOc1ccc2c(c1)nc(N(Cc1ccc(C(=O)Nc3nn[nH]n3)cc1)C1CCC(C(C)(C)C)CC1)n2C.
What is the InChIKey of 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-prop-2-enoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide?
The InChIKey is RGBCQKRUFCGDTG-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H38N8O2/c1-6-17-40-24-15-16-26-25(18-24)31-29(37(26)5)38(23-13-11-22(12-14-23)30(2,3)4)19-20-7-9-21(10-8-20)27(39)32-28-33-35-36-34-28/h6-10,15-16,18,22-23H,1,11-14,17,19H2,2-5H3,(H2,32,33,34,35,36,39).
What are the key properties of 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-prop-2-enoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide?
4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-prop-2-enoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide has a molecular weight of 542.69 g/mol, XLogP of 5.51, 9 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-prop-2-enoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide is sourced from PubChem (CID 11432704), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).